Cardioprotective effect of liposomal prostaglandin E1 on a porcine model of myocardial infarction reperfusion no-reflow

Journal of Zhejiang University: Science B

Volumn 12, Issue 8, 2011, Pages 638-643

  Li, Jia Hui ^a   Yang, Peng ^a   Li, Ai Li ^a   Wang, Yong ^a   Ke, Yuan Nan ^a   Li, Xian Lun ^a  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Liposomal prostaglandin E1 (lipo PGE1); Myocardial infarction; Reperfusion no reflow

Indexed keywords

CARDIOVASCULAR AGENT; INTERLEUKIN 6; LIPOSOMAL PROSTAGLANDIN E1; PROSTAGLANDIN E1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; DRUG MECHANISM; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEMODYNAMICS; INFLAMMATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY; NO REFLOW PHENOMENON; NONHUMAN; PRIORITY JOURNAL; SHAM PROCEDURE; STAINING; SWINE; SYSTOLIC BLOOD PRESSURE;

ALGORITHMS; ALPROSTADIL; ANIMALS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; INTERLEUKIN-6; LIPOSOMES; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIUM; RADIOIMMUNOASSAY; RANDOM ALLOCATION; SWINE; SWINE, MINIATURE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

SUS;

EID: 80055009041     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B1101007     Document Type: Article

References (10)

1. Fozzard, H.A., 1975. Validity of myocardial infarction models. Circulation, 52(6 Suppl.):III131-III146.
2. He, Z.F., Li, Z.J., 2004. Prostaglandin E1 reduces reperfusion injury of myocardium by inhibiting cytokines production during cardiac surgery. J. Zhejiang Univ. (Med. Sci.), 33(4):353-356 (in Chinese).
3. Jaffe, R., Charron, T., Puley, G., Dick, A., Strauss, B.H., 2008. Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation, 117(24):3152-3156. [doi:10.1161/ CIRCULATIONAHA. 107.742312]
4. Kawamura, T., Nara, N., Kadosaki, M., Inada, K., Endo, S., 2000. Prostaglandin E1 reduces myocardial reperfusion injury by inhibiting proinflammatory cytokines production during cardiac surgery. Crit. Care Med., 28(7): 2201-2208. [doi:10.1097/00003246-200007000-00004] (Pubitemid 30604416)
5. Krombach, G.A., Kinzel, S., Mahnken, A.H., Gunther, R.W., Buecker, A., 2005. Minimally invasive close-chest method for creating reperfused or occlusive myocardial infarction in swine. Invest. Radiol., 40(1):14-18. (Pubitemid 40029889)
6. Morishima, I., Sone, T., Okumura, K., Tsuboi, H., Kondo, J., Mukawa, H., Matsui, H., Toki, Y., Ito, T., Hayakawa, T., 2000. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J. Am. Coll. Cardiol., 36(4): 1202-1209. [doi:10.1016/S0735-1097(00) 00865-2]
7. Reffelmann, T., Sensebat, O., Birnbaum, Y., Stroemer, E., Hanrath, P., Uretsky, B.F., Schwarz, E.R., 2004. A novel minimal-invasive model of chronic myocardial infarction in swine. Coronary Artery Dis., 15(1):7-12. (Pubitemid 39117994)
8. Smalling, R.W., Feld, S., Ramanna, N., Amirian, J., Felli, P., Vaughn, W.K., Swenson, C., Janoff, A., 1995. Infarct salvage with liposomal prostaglandin E1 administered by intravenous bolus immediately before reperfusion in a canine infarction-reperfusion model. Circulation, 92(4): 935-943.
9. Suzuki, Y., Lyons, J.K., Yeung, A.C., Ikeno, F., 2008. In vivo porcine model of reperfused myocardial infarction: in situ double staining to measure precise infarct area/area at risk. Catheter Cardiovasc. Interv., 71(1):100-107. [doi:10. 1002/ccd.21329] (Pubitemid 351158353)
10. Wang, J.A., Luo, R.H., Zhang, X., Xie, X.J., Hu, X.Y., He, A.N., Chen, J., Li, J.H., 2006. Bone marrow mesenchymal stem cell transplantation combined with perindopril treatment attenuates infarction remodeling in a rat model of acute myocardial infarction. J. Zhejiang Univ.-Sci. B, 7(8):641-647. [doi:10.1631/jzus.2006.B0641]